Cicatrix Clinical Trial
Official title:
Observational Study for the Long-Term Effects of a Dermal Substitute on Patients With Facial Burns.
Verified date | May 2019 |
Source | Universitair Ziekenhuis Brussel |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this observational study is to investigate the long-term (between 10-20 years)
results for the surgical treatment of third degree burn injury in the face and/or the neck by
means of Integra® Dermal Regeneration Template.
This study is an observational case-control study. The healthy skin of a comparable and/or
contralateral skin-site of the face/neck serves as a comparator.
The population consists of human volunteers between 18 and 75 years old with third degree
full thickness burn injuries in the face and/or neck, who underwent surgical treatment with
IDRT between 1998 and 2008.
Status | Completed |
Enrollment | 8 |
Est. completion date | February 14, 2019 |
Est. primary completion date | February 14, 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - The subjects must be between 18 and 75 years old. - Third degree full thickness burn injuries in the face and/or neck - Having received surgical treatment with IDRT. - Underwent surgery between 1998 and 2008. Exclusion Criteria: - Subjects with no matching control site comparable with assessed body location. |
Country | Name | City | State |
---|---|---|---|
Belgium | Queen Astrid Military Hospital | Neder-Over-Heembeek |
Lead Sponsor | Collaborator |
---|---|
Universitair Ziekenhuis Brussel | Organisation for Burns, Scar Aftercare and Research |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | POSAS Patient Scale Total Sum of Scores | The POSAS Patient Scale contains six items (pain, itch, colour, thickness, pliability, texture) that are scored numerically on a ten-step scale from 1 (= healthy skin) to 10 (= worst imaginable scar). Together they make up the 'Total Sum of Scores'. | at enrolment | |
Secondary | POSAS Observer Scale Total Sum of Scores | The POSAS Observer Scale contains six items (vascularity, pigmentation, thickness, pliability, surface, texture) that are scored numerically on a ten-step scale from 1 (= healthy skin) to 10 (= worst imaginable scar). Together they make up the 'Total Sum of Scores'. | at enrolment | |
Secondary | Objective colour measurements with Mexameter | Mexameter is an objective assessment tool to measure erythema and pigmentation of the skin. | at enrolment | |
Secondary | Objective thickness measurements with High Frequency Ultrasound | With High Frequency Ultrasound one can measure the thickness of the dermis in µm. | at enrolment | |
Secondary | Objective elasticity measurements with Cutometer | Elasticity is measured objectively by means of skin suction. | at enrolment | |
Secondary | Objective TEWL measurements with Tewameter | The Tewameter measures the evaporation of water from the skin. | at enrolment | |
Secondary | Quality of Life Questionnaire EQ5D | This questionnaire assesses the mental and physical health and their consequences on quality of life. It is a generic questionnaire. | at enrolment | |
Secondary | Quality of Life Questionnaire SF-36 | This questionnaire assesses the mental and physical health and their consequences on quality of life. It is a generic questionnaire. | at enrollment | |
Secondary | Quality of Life Questionnaire BSHS-B | This questionnaire assesses the mental and physical health and their consequences on quality of life. It is a disease-specific questionnaire for patients with burn injuries. | at enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02645773 -
Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring
|
N/A | |
Completed |
NCT02672956 -
Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results
|
N/A | |
Completed |
NCT00629811 -
Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women
|
Phase 2 | |
Completed |
NCT00977951 -
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
|
Phase 1/Phase 2 | |
Completed |
NCT00847795 -
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03213548 -
Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty
|
N/A | |
Recruiting |
NCT05377723 -
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
|
N/A | |
Active, not recruiting |
NCT01976260 -
A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
|
N/A | |
Terminated |
NCT00432328 -
Juvista (Avotermin) in Breast Reduction Surgery Scars
|
Phase 2 | |
Completed |
NCT00984503 -
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites
|
Phase 2 | |
Completed |
NCT00594581 -
Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males
|
Phase 2 | |
Recruiting |
NCT04420442 -
Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars
|
N/A | |
Completed |
NCT02772289 -
Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
|
Phase 2 | |
Completed |
NCT00430326 -
Juvista (Avotermin) in Scars Following Varicose Vein Removal
|
Phase 2 | |
Completed |
NCT00847925 -
Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects
|
Phase 1/Phase 2 | |
Recruiting |
NCT05787171 -
Three Sutures With Different Absorption Rates for Lower Abdominal Incision
|
N/A | |
Completed |
NCT02985151 -
Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy
|
N/A | |
Completed |
NCT02340325 -
FS2 Safety and Tolerability Study in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT00432211 -
Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.
|
Phase 2 | |
Completed |
NCT00978302 -
Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)
|
Phase 1 |